BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21879092)

  • 1. Rattle-type hollow CaWO4:Tb(3+)@SiO2 nanocapsules as carriers for drug delivery.
    Zhai X; Yu M; Cheng Z; Hou Z; Ma P; Yang D; Kang X; Dai Y; Wang D; Lin J
    Dalton Trans; 2011 Dec; 40(48):12818-25. PubMed ID: 21879092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
    Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
    ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cells.
    Wang TT; Chai F; Wang CG; Li L; Liu HY; Zhang LY; Su ZM; Liao Y
    J Colloid Interface Sci; 2011 Jun; 358(1):109-15. PubMed ID: 21453927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YVO4:Eu3+ functionalized porous silica submicrospheres as delivery carriers of doxorubicin.
    Cheng Z; Ma P; Hou Z; Wang W; Dai Y; Zhai X; Lin J
    Dalton Trans; 2012 Feb; 41(5):1481-9. PubMed ID: 22124278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rattle-type Fe(3)O(4)@SiO(2) hollow mesoporous spheres as carriers for drug delivery.
    Zhu Y; Ikoma T; Hanagata N; Kaskel S
    Small; 2010 Feb; 6(3):471-8. PubMed ID: 19943250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Template-etching route to construct uniform rattle-type Fe
    Cheng L; Liu Y; Zou B; Yu Y; Ruan W; Wang Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():829-835. PubMed ID: 28415536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPMV-induced synthesis of hollow mesoporous SiO2 nanocapsules with excellent performance in drug delivery.
    Kumar K; Kumar Doddi S; Arunasree MK; Paik P
    Dalton Trans; 2015 Mar; 44(9):4308-17. PubMed ID: 25640798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A luminescent and mesoporous core-shell structured Gd2O3 : Eu(3+)@nSiO2@mSiO2 nanocomposite as a drug carrier.
    Xu Z; Gao Y; Huang S; Ma Pa; Lin J; Fang J
    Dalton Trans; 2011 May; 40(18):4846-54. PubMed ID: 21431226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery.
    Wu Y; Yang D; Kang X; Ma P; Huang S; Zhang Y; Li C; Lin J
    Dalton Trans; 2013 Jul; 42(27):9852-61. PubMed ID: 23689234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hollow structured upconversion luminescent NaYF₄:Yb³⁺, Er³⁺ nanospheres for cell imaging and targeted anti-cancer drug delivery.
    Yang D; Kang X; Ma P; Dai Y; Hou Z; Cheng Z; Li C; Lin J
    Biomaterials; 2013 Feb; 34(5):1601-12. PubMed ID: 23199935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-responsive drug delivery system based on luminescent CaF(2):Ce(3+)/Tb(3+)-poly(acrylic acid) hybrid microspheres.
    Dai Y; Zhang C; Cheng Z; Ma P; Li C; Kang X; Yang D; Lin J
    Biomaterials; 2012 Mar; 33(8):2583-92. PubMed ID: 22196902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics.
    Liu Y; Miyoshi H; Nakamura M
    Colloids Surf B Biointerfaces; 2007 Aug; 58(2):180-7. PubMed ID: 17420116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monodisperse core-shell structured up-conversion Yb(OH)CO₃@YbPO₄:Er³+ hollow spheres as drug carriers.
    Xu Z; Ma P; Li C; Hou Z; Zhai X; Huang S; Lin J
    Biomaterials; 2011 Jun; 32(17):4161-73. PubMed ID: 21435712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanorod-covered kanamycin-loaded hollow SiO2 (HSKAu(rod)) nanocapsules for drug delivery and photothermal therapy on bacteria.
    Hu B; Zhang LP; Chen XW; Wang JH
    Nanoscale; 2013 Jan; 5(1):246-52. PubMed ID: 23154667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
    Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y
    ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.
    Shen Y; Jin E; Zhang B; Murphy CJ; Sui M; Zhao J; Wang J; Tang J; Fan M; Van Kirk E; Murdoch WJ
    J Am Chem Soc; 2010 Mar; 132(12):4259-65. PubMed ID: 20218672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hollow silica nanocontainers as drug delivery vehicles.
    Yang J; Lee J; Kang J; Lee K; Suh JS; Yoon HG; Huh YM; Haam S
    Langmuir; 2008 Apr; 24(7):3417-21. PubMed ID: 18324841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.
    Yuan H; Bao X; Du YZ; You J; Hu FQ
    Int J Nanomedicine; 2012; 7():5119-28. PubMed ID: 23055724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route.
    Kang X; Huang S; Yang P; Ma P; Yang D; Lin J
    Dalton Trans; 2011 Mar; 40(9):1873-9. PubMed ID: 21183970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.